Insider Trading History of Lebel Carl

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lebel Carl since 2015. This trader's CIK number is 1439275. At the time of last reporting, Lebel Carl was the Chief Development Officer of Frequency Therapeutics, Inc.. (stock ticker symbol FREQ). Also see all insider trading activities at Frequency Therapeutics, Inc..

Note that in the past LeBel Carl also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Otonomy, Inc. (OTIC) by Lebel Carl

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 OTIC 0 $0 31,875 $573,441 31,875 $160,303
2015 OTIC 0 $0 42,500 $1,114,817 42,500 $186,893

Yearly summary of insider trading at Frequency Therapeutics, Inc. (FREQ) by Lebel Carl

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 FREQ 0 $0 9,040 $25,372 30,000 $0


Insider trading activities at 2 companies by Lebel Carl:

1. Otonomy, Inc. (OTIC)

2. Frequency Therapeutics, Inc. (FREQ)

Table 1. Insider trading of Otonomy, Inc. (OTIC) by Lebel Carl

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-11-18 OTIC Option Ex 9,169 4.75 43,552
2016-11-18 OTIC Sale 9,169 18.07 165,702
2016-11-21 OTIC Option Ex 1,456 3.17 4,615
2016-11-21 OTIC Sale 1,456 18.07 26,302
2016-09-06 OTIC Option Ex 21,250 5.28 112,136
2016-09-06 OTIC Sale 21,250 17.95 381,437
2015-12-21 OTIC Sale 21,250 28.11 597,231
2015-12-21 OTIC Option Ex 21,250 4.75 100,937
2015-09-21 OTIC Option Ex 21,250 4.04 85,956
2015-09-21 OTIC Sale 21,250 24.36 517,586

Table 2. Insider trading of Frequency Therapeutics, Inc. (FREQ) by Lebel Carl

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-07-05 FREQ Option Ex 15,000 .00 0
2022-07-06 FREQ Sale 4,421 1.52 6,719
2022-02-18 FREQ Sale 974 3.87 3,772
2022-02-22 FREQ Sale 1,069 3.53 3,772
2022-02-17 FREQ Sale 901 4.19 3,774
2022-02-16 FREQ Sale 831 4.43 3,680
2022-02-14 FREQ Option Ex 15,000 .00 0
2022-02-15 FREQ Sale 844 4.33 3,655

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lebel Carl (Chief Development Officer of Frequency Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.